AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35304745 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-hour magnesium sulfate regimen
Number of subjects: 1176
Study 34881663 — intervention group
Group type: EXPERIMENTAL
Intervention: Thinking Healthy Programme Peer‐delivered (THPP)
Number of subjects: 0
Study 35115017 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation services in LAC-LACDHS-operated outpatient primary care clinics and LAC-LACDMH-operated community mental health clinics
Number of subjects: 1200
Study 35115017 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual in clinics
Number of subjects: 1200
Study 34819058 — intervention group
Group type: COMPARATOR
Intervention: CHTC as usual
Number of subjects: 2
Study 34819058 — intervention group
Group type: EXPERIMENTAL
Intervention: CHTC plus CT video
Number of subjects: 2
Study 34819058 — intervention group
Group type: EXPERIMENTAL
Intervention: CHTC plus SUM
Number of subjects: 2
Study 34819058 — intervention group
Group type: EXPERIMENTAL
Intervention: CHTC plus CT video + SUM
Number of subjects: 2
Study 36048348 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of daily injectable vitamin B12
Number of subjects: 72
Study 36048348 — intervention group
Group type: COMPARATOR
Intervention: 1 mg of daily injectable vitamin B12 with other multinutrients (B12 + MV)
Number of subjects: 72
Study 34717169 — intervention group
Group type: EXPERIMENTAL
Intervention: Single set of acute care scenarios
Number of subjects: 146
Study 34717169 — intervention group
Group type: COMPARATOR
Intervention: Double set of acute care scenarios
Number of subjects: 146
Study 33360642 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised exercise programme (12-week duration, including balance, endurance, strength, and flexibility training)
Number of subjects: 14
Study 33360642 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised exercise programme
Number of subjects: 14
Study 33360642 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal daily activities)
Number of subjects: 14
Study 33360642 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study 32493052 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous continuous infusion (CI) of midazolam
Number of subjects: 99
Study 32493052 — intervention group
Group type: COMPARATOR
Intervention: Intravenous intermittent bolus (IB) doses of midazolam
Number of subjects: 99
Study 36197264 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication combined with schedule exercise therapy (MSET)
Number of subjects: 118
Study 36197264 — intervention group
Group type: COMPARATOR
Intervention: Medication (MED)
Number of subjects: 118
Study 36197264 — intervention group
Group type: EXPERIMENTAL
Intervention: All subjects combined
Number of subjects: 118
Study 34117276 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 101
Study 34117276 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance-strength training
Number of subjects: 101
Study 32358086 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-EB-PSMA 2.12 ± 0.19 GBq (Group B)
Number of subjects: 28
Study 32358086 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-EB-PSMA 3.52 ± 0.58 GBq (Group C)
Number of subjects: 28
Study 32358086 — intervention group
Group type: COMPARATOR
Intervention: 177Lu-EB-PSMA 1.18 ± 0.09 GBq (Group A)
Number of subjects: 28
Study 32358086 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-EB-PSMA (all groups)
Number of subjects: 28
Study 32358086 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-EB-PSMA (Group B and C)
Number of subjects: 28
Study 35576129 — intervention group
Group type: EXPERIMENTAL
Intervention: FMS Group (coaching the Australian recommended fundamental overarm throwing skill criteria)
Number of subjects: 97
Study 35576129 — intervention group
Group type: COMPARATOR
Intervention: Sports Group (skilled sports-active pupils)
Number of subjects: 97
Study 36418536 — intervention group
Group type: EXPERIMENTAL
Intervention: Active device emitting UVB light (peak wavelength of 285 nm)
Number of subjects: 136
Study 36418536 — intervention group
Group type: COMPARATOR
Intervention: Sham device emitting visible light
Number of subjects: 136
Study 33667155 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing interventions based on Dennis's Breastfeeding Self‐Efficacy Theory and Pender's Health Promotion Model during home visits
Number of subjects: 60
Study 33667155 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study 33667155 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing interventions
Number of subjects: 60
Study 32272181 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymoquinone (TQ) combined with arsenic/interferon-alpha (As/IFN-α)
Number of subjects: 4
Study 32272181 — intervention group
Group type: COMPARATOR
Intervention: Arsenic/interferon-alpha (As/IFN-α)
Number of subjects: 4
Study 32272181 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymoquinone (TQ) alone or in combination
Number of subjects: 4
Study 33579652 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‐mo Mediterranean diet and moderate physical activity program
Number of subjects: 263
Study 33579652 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 263
Study 33709982 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure (BP) control
Number of subjects: 0
Study 33709982 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapies
Number of subjects: 0
Study 33709982 — intervention group
Group type: COMPARATOR
Intervention: Current BP targets
Number of subjects: 0
Study 32951743 — intervention group
Group type: EXPERIMENTAL
Intervention: δ‐tocotrienol 300 mg twice daily
Number of subjects: 71
Study 32951743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 35774629 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic scapular recognition exercise with vertical downward correction using rigid taping (50% to 75% tension)
Number of subjects: 67
Study 35774629 — intervention group
Group type: COMPARATOR
Intervention: Dynamic scapular recognition exercise with sham taping
Number of subjects: 67
Study 33392754 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibula tunnel drilling during PLC reconstruction
Number of subjects: 101
Study 33413489 — intervention group
Group type: EXPERIMENTAL
Intervention: PRECIS-2-PS tool
Number of subjects: 0
Study 32619630 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rehabilitation program (8 weeks duration)
Number of subjects: 59
Study 32619630 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rehabilitation program
Number of subjects: 59
Study 32619630 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 59
Study 33070253 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (specific antibody to human RANKL)
Number of subjects: 0
Study 36130764 — intervention group
Group type: EXPERIMENTAL
Intervention: Better WASH practices
Number of subjects: 193576
Study 36130764 — intervention group
Group type: COMPARATOR
Intervention: Not better WASH practices
Number of subjects: 193576
Study 32929721 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoseal MTA
Number of subjects: 90
Study 32929721 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoSequence BC Sealer
Number of subjects: 90
Study 32929721 — intervention group
Group type: EXPERIMENTAL
Intervention: AH Plus
Number of subjects: 90
Study 32942053 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 180
Study 32942053 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (standard care for 16 weeks)
Number of subjects: 180
Study 34662890 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (2.5 mg twice daily, later increased to 5 mg twice daily)
Number of subjects: 48
Study 34662890 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (target international normalized ratio 2-3)
Number of subjects: 48
Study 33400618 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-balanced energy availability without exercise (BAL; 45 kcal·kg LBM-1·day-1)
Number of subjects: 20
Study 33400618 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-induced low energy availability (EX; 15 kcal·kg LBM-1·day-1, including 30 kcal·kg LBM-1·day-1 treadmill running at 70% maximal oxygen uptake)
Number of subjects: 20
Study 33400618 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-induced low energy availability (DIET; 15 kcal·kg LBM-1·day-1)
Number of subjects: 20
Study 36326770 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity transcutaneous electrical stimulation of the right auricular branch (25 Hz, 50 mA) for 20 minutes prior to anesthesia
Number of subjects: 134
Study 36326770 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 134
Study 36326770 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity transcutaneous electrical stimulation of the right auricular branch
Number of subjects: 134
Study 34444833 — intervention group
Group type: EXPERIMENTAL
Intervention: Coach-directed weight loss (behavioral telephonic coaching)
Number of subjects: 121
Study 34444833 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (up to 2000 mg daily)
Number of subjects: 121
Study 34444833 — intervention group
Group type: COMPARATOR
Intervention: Self-directed weight loss (informational brochures)
Number of subjects: 121
Study 32611451 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity, high frequency peer reminders (monthly)
Number of subjects: 349
Study 32611451 — intervention group
Group type: COMPARATOR
Intervention: Quarterly peer reminders
Number of subjects: 349
Study 32611451 — intervention group
Group type: COMPARATOR
Intervention: Monthly paper-based reminders
Number of subjects: 349
Study 32611451 — intervention group
Group type: COMPARATOR
Intervention: Quarterly paper-based reminders
Number of subjects: 349
Study 35620782 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS)
Number of subjects: 0
Study 35620782 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study 36056721 — intervention group
Group type: EXPERIMENTAL
Intervention: SAA-reduced formula diet (LowS group)
Number of subjects: 115
Study 36056721 — intervention group
Group type: COMPARATOR
Intervention: Regular formula diet (control group)
Number of subjects: 115
Study 32179696 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal assisted laparoscopic radical hysterectomy (VALRH)
Number of subjects: 389
Study 32179696 — intervention group
Group type: COMPARATOR
Intervention: Open abdominal radical hysterectomy
Number of subjects: 389
Study 33234670 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Mediterranean diet
Number of subjects: 294
Study 33234670 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 294
Study 33234670 — intervention group
Group type: COMPARATOR
Intervention: Healthy dietary guidance (HDG)
Number of subjects: 294
Study 32000828 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg aspirin for 6 months after index ERBD
Number of subjects: 184
Study 32000828 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months after index ERBD
Number of subjects: 184
Study 35443676 — intervention group
Group type: EXPERIMENTAL
Intervention: DF-HA 30 mg
Number of subjects: 290
Study 35443676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study 33367782 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone monoester (KME) drink containing 12 g β‐OHB
Number of subjects: 14
Study 33367782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 33484897 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational and Empowerment (E2) intervention with Post‐Acute Care Hypertension Consultation (PACHT‐c) and mobile health BP self‐monitoring kit
Number of subjects: 770
Study 33484897 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 770
Study 33484897 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational and Empowerment (E2) intervention
Number of subjects: 770
Study 34738243 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (structured curricula, play materials, nutrition, training and supervision)
Number of subjects: 110
Study 34738243 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 110
Study 32376326 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based video game exercises (60 minutes, 3 times per week for 8 weeks)
Number of subjects: 60
Study 32376326 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based video game exercises
Number of subjects: 60
Study 32376326 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintain usual levels of activity and care seeking behaviors)
Number of subjects: 60
Study 36219198 — intervention group
Group type: EXPERIMENTAL
Intervention: Furocyst® (2 capsules of 500 mg/day)
Number of subjects: 208
Study 36219198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study 33946212 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed tree nuts (MTNs)
Number of subjects: 95
Study 33946212 — intervention group
Group type: COMPARATOR
Intervention: Refined carbohydrate pretzel snack (PS)
Number of subjects: 95
Study 35440463 — intervention group
Group type: EXPERIMENTAL
Intervention: Fit-For-Fertility Programme (FFFP) for 6 months, then in combination with usual care for infertility if not pregnant; intervention duration up to 18 months or 24 months if pregnant.
Number of subjects: 616
Study 35440463 — intervention group
Group type: COMPARATOR
Intervention: Usual fertility care (control arm).
Number of subjects: 616
Study 35440463 — intervention group
Group type: EXPERIMENTAL
Intervention: FFFP and usual care for infertility if not pregnant.
Number of subjects: 616
Study 33571950 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 205
Study 33571950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 33936396 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model (Bi-LSTM-CRF) for extracting eligibility criteria
Number of subjects: 100
Study 34331930 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual sufentanil cartridges (Zalviso)
Number of subjects: 80
Study 34331930 — intervention group
Group type: COMPARATOR
Intervention: Intravenous pain management (Control)
Number of subjects: 80
Study 33870785 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based Pilates (twice-weekly, guided by a DVD)
Number of subjects: 80
Study 33870785 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 80
Study 32810055 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard PA curriculum plus EBM training
Number of subjects: 61
Study 32810055 — intervention group
Group type: COMPARATOR
Intervention: Standard PA curriculum only
Number of subjects: 61
Study 33864068 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels of 500-999 MET-min/week
Number of subjects: 465
Study 33864068 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels of 2000+ MET-min/week
Number of subjects: 465
Study 33864068 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieving at least 90 MET-min/week of PA
Number of subjects: 465
Study 33864068 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 465
Study 33864068 — intervention group
Group type: EXPERIMENTAL
Intervention: High NFL levels
Number of subjects: 465
Study 32087597 — intervention group
Group type: EXPERIMENTAL
Intervention: Tape applied from muscle origin to insertion (facilitation)
Number of subjects: 27
Study 32087597 — intervention group
Group type: EXPERIMENTAL
Intervention: Tape applied from muscle insertion to origin (inhibition)
Number of subjects: 27
Study 32087597 — intervention group
Group type: COMPARATOR
Intervention: Baseline (without tape)
Number of subjects: 27
Study 34374633 — intervention group
Group type: EXPERIMENTAL
Intervention: six 20-minute sessions of moderate-intensity walking
Number of subjects: 44
Study 34374633 — intervention group
Group type: COMPARATOR
Intervention: assessment-only control
Number of subjects: 44
Study 33667420 — intervention group
Group type: EXPERIMENTAL
Intervention: R-MegaCHOEP (high-dose chemotherapy plus rituximab followed by autologous HSCT)
Number of subjects: 275
Study 33667420 — intervention group
Group type: COMPARATOR
Intervention: R-CHOEP-14 (conventional chemotherapy plus rituximab)
Number of subjects: 275
Study 33667420 — intervention group
Group type: EXPERIMENTAL
Intervention: R-MegaCHOEP
Number of subjects: 275
Study 33667420 — intervention group
Group type: COMPARATOR
Intervention: R-CHOEP-14
Number of subjects: 275
Study 33667420 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 275
Study 35859288 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization exercises in addition to traditional scoliosis exercises for 8 weeks
Number of subjects: 30
Study 35859288 — intervention group
Group type: COMPARATOR
Intervention: Traditional scoliosis exercises for 8 weeks
Number of subjects: 30
Study 33333147 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR variability
Number of subjects: 7520
Study 33429762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.2 μg/kg/hour (group D1)
Number of subjects: 90
Study 33429762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.4 μg/kg/hour (group D2)
Number of subjects: 90
Study 33429762 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline 0.2 μg/kg/hour (group C)
Number of subjects: 90
Study 32470201 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for type 2 diabetes mellitus
Number of subjects: 20184
Study 34228099 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoguided strategy (prophylaxis until CMV-CMI recovery)
Number of subjects: 150
Study 34228099 — intervention group
Group type: COMPARATOR
Intervention: Fixed-duration prophylaxis (until day 90)
Number of subjects: 150
Study 33469090 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicon (2.5 mM) added to nutrient solution
Number of subjects: 5
Study 33469090 — intervention group
Group type: COMPARATOR
Intervention: Calcium sufficiency (5 mM) without silicon
Number of subjects: 5
Study 32790453 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention (IBI) for psychosis
Number of subjects: 101
Study 32790453 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 101
Study 35292837 — intervention group
Group type: EXPERIMENTAL
Intervention: ViVi® SSHS with HFD Hood (saccharin cohort)
Number of subjects: 40
Study 35292837 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo cohort)
Number of subjects: 40
Study 36125020 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser guidance on mini C-arm
Number of subjects: 25
Study 36125020 — intervention group
Group type: COMPARATOR
Intervention: No laser guidance on mini C-arm
Number of subjects: 25
Study 33526397 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Vancomycin Powder and Dilute Povidone-Iodine (VIP) protocol
Number of subjects: 18299
Study 33526397 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-VIP protocol)
Number of subjects: 18299
Study 32240909 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (SCRT) followed by chemotherapy (6 cycles CAPOX or 9 cycles FOLFOX4)
Number of subjects: 901
Study 32240909 — intervention group
Group type: COMPARATOR
Intervention: Long-course radiotherapy (25-28 × 2-1.8 Gy) with concomitant capecitabine followed by surgery and optional postoperative chemotherapy (8 cycles CAPOX or 12 cycles FOLFOX4)
Number of subjects: 901
Study 36190481 — intervention group
Group type: COMPARATOR
Intervention: 20,000 IU/10 d (standard dose)
Number of subjects: 82
Study 36190481 — intervention group
Group type: EXPERIMENTAL
Intervention: 60,000 IU/10 d (high dose)
Number of subjects: 82
Study 32267568 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat forward-view (RF) examination of the right-sided colon
Number of subjects: 640
Study 32267568 — intervention group
Group type: COMPARATOR
Intervention: Standard forward-view (SF) examination of the right-sided colon
Number of subjects: 640
Study 35631145 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitadio (digital program)
Number of subjects: 100
Study 35631145 — intervention group
Group type: COMPARATOR
Intervention: In-person consultations (control group)
Number of subjects: 100
Study 34087194 — intervention group
Group type: EXPERIMENTAL
Intervention: Street view greenness (IQR = 3.6%)
Number of subjects: 24845
Study 34087194 — intervention group
Group type: EXPERIMENTAL
Intervention: Street view greenness
Number of subjects: 24845
Study 32040341 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-gene signature (including one long noncoding RNA and four protein-coding genes)
Number of subjects: 757
Study 32040341 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-gene signature
Number of subjects: 757
Study 35214798 — intervention group
Group type: COMPARATOR
Intervention: ShigETEC vaccine (5 × 10^10 colony forming units)
Number of subjects: 0
Study 35214798 — intervention group
Group type: EXPERIMENTAL
Intervention: ShigETEC vaccine
Number of subjects: 0
Study 34562773 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive attitude plus positive affect message
Number of subjects: 484
Study 34562773 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no message)
Number of subjects: 484
Study 35221255 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricular septal pacing
Number of subjects: 141
Study 35221255 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular apical pacing
Number of subjects: 141
Study 33081606 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) 100 µg/25 µg
Number of subjects: 283
Study 33081606 — intervention group
Group type: COMPARATOR
Intervention: Vilanterol (VI) 25 µg
Number of subjects: 283
Study 33081606 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 283
Study 35584932 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel single antiplatelet therapy (SAPT) after short-term dual antiplatelet therapy (DAPT)
Number of subjects: 1107
Study 35584932 — intervention group
Group type: COMPARATOR
Intervention: Long-term dual antiplatelet therapy (DAPT)
Number of subjects: 1107
Study 32047100 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversations with a doctor about HIV testing
Number of subjects: 699